75 results on '"Silke Neumann"'
Search Results
2. Cutting-edge advances in modeling the blood–brain barrier and tools for its reversible permeabilization for enhanced drug delivery into the brain
- Author
-
Amit Sharma, Diogo C. Fernandes, Rui L. Reis, Dominika Gołubczyk, Silke Neumann, Barbara Lukomska, Miroslaw Janowski, Marcin Kortylewski, Piotr Walczak, J. Miguel Oliveira, and Jarek Maciaczyk
- Subjects
Blood–brain barrier ,Drug targets ,In vitro models ,In vivo models ,Drug delivery ,Organoid models ,Biotechnology ,TP248.13-248.65 ,Biology (General) ,QH301-705.5 ,Biochemistry ,QD415-436 - Abstract
Abstract The blood–brain barrier (BBB) is a sophisticated structure whose full functionality is required for maintaining the executive functions of the central nervous system (CNS). Tight control of transport across the barrier means that most drugs, particularly large size, which includes powerful biologicals, cannot reach their targets in the brain. Notwithstanding the remarkable advances in characterizing the cellular nature of the BBB and consequences of BBB dysfunction in pathology (brain metastasis, neurological diseases), it remains challenging to deliver drugs to the CNS. Herein, we outline the basic architecture and key molecular constituents of the BBB. In addition, we review the current status of approaches that are being explored to temporarily open the BBB in order to allow accumulation of therapeutics in the CNS. Undoubtedly, the major concern in field is whether it is possible to open the BBB in a meaningful way without causing negative consequences. In this context, we have also listed few other important key considerations that can improve our understanding about the dynamics of the BBB.
- Published
- 2023
- Full Text
- View/download PDF
3. Healthy grocery delivery in the usual care for adults recovering from an acute coronary event: protocol for a three-arm randomised controlled trial
- Author
-
Jim Mann, Sean Coffey, Huan Chan, Robin Turner, Alastair Ross, Ross Wilson, Fiona Hood, Ella Iosua, Andrew N Reynolds, Silke Neumann, Rajesh Katare, Aysu Shahin, and Zi-yi Kok
- Subjects
Medicine - Abstract
Introduction Coronary heart disease is a major contributor to the global burden of disease. Appropriate nutrition is a cornerstone of the prevention and treatment of coronary heart disease; however, barriers including cost and access to recommended foods limits long-term adherence for many. We are conducting, in adults with coronary heart disease, a randomised controlled trial comparing usual care with two dietary interventions in which usual care is augmented by 12 weeks free delivered groceries.Methods and analysis Three hundred adults recovering from an acute coronary event will be recruited from outpatient cardiovascular services in three regions of Aotearoa New Zealand. Participants will be randomly allocated to three arms: usual care (control group), usual care and the free delivery of foods high in dietary fibre or usual care and the free delivery of foods high in unsaturated fats. Interventions duration is 12 weeks, with a further 12 months follow-up. The primary outcome measures are change in low-density lipoprotein (LDL) cholesterol concentration following the intervention, and a cost-effectiveness analysis of healthcare access and social costs in the year after the intervention. A broad range of secondary outcome measures include other blood lipids, anthropometry, glycaemia, inflammatory markers, gut microbiome, dietary biomarkers, food acceptability, dietary change and the facilitators and barriers to dietary change. The trial will determine whether the free provision of groceries known to reduce cardiovascular risk within usual care will be clinically beneficial and justify the cost of doing so. Results may also provide an indication of the relative benefit of foods rich in dietary fibre or unsaturated fats in coronary heart disease management.Ethics and dissemination This trial, The Healthy Heart Study, has Health and Disability Ethics Committee approval (20/NTB/121), underwent Māori consultation, and has locality authority to be conducted in Canterbury, Otago and Southland.Trial registration number ACTRN12620000689976, U1111-1250-1499.
- Published
- 2023
- Full Text
- View/download PDF
4. Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies
- Author
-
Nicholas J. Shields, Estelle M. Peyroux, Angela L. Ferguson, Megan Steain, Silke Neumann, and Sarah L. Young
- Subjects
colorectal cancer ,immunotherapy ,syngeneic preclinical models ,MC38 ,immune exclusion ,t cell exhaustion ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Anti-tumour T cell responses play a crucial role in controlling the progression of colorectal cancer (CRC), making this disease a promising candidate for immunotherapy. However, responses to immune-targeted therapies are currently limited to subpopulations of patients and specific types of cancer. Clinical studies have therefore focussed on identifying biomarkers that predict immunotherapy responses and elucidating the immunological landscapes of different cancers. Meanwhile, our understanding of how preclinical tumour models resemble human disease has fallen behind, despite their crucial role in immune-targeted drug development. A deeper understanding of these models is therefore needed to improve the development of immunotherapies and the translation of findings made in these systems. MC38 colon adenocarcinoma is a widely used preclinical model, yet how it recapitulates human colorectal cancer remains poorly defined. This study investigated the tumour-T cell immune landscape of MC38 tumours using histology, immunohistochemistry, and flow cytometry. We demonstrate that early-stage tumours exhibit a nascent TME, lacking important immune-resistance mechanisms of clinical interest, while late-stage tumours exhibit a mature TME resembling human tumours, with desmoplasia, T cell exhaustion, and T cell exclusion. Consequently, these findings clarify appropriate timepoint selection in the MC38 model when investigating both immunotherapies and mechanisms that contribute to immunotherapy resistance. Overall, this study provides a valuable resource that will enable appropriate application of the MC38 model and expedite the development and clinical translation of new immunotherapies.
- Published
- 2023
- Full Text
- View/download PDF
5. Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells
- Author
-
Philippe Aretz, Donata Maciaczyk, Suad Yusuf, Rüdiger V. Sorg, Daniel Hänggi, Hongjia Liu, Hongde Liu, Tikam Chand Dakal, Amit Sharma, Ramakrishna Bethanabatla, Silke Neumann, and Jarek Maciaczyk
- Subjects
glioblastoma ,GSCs ,β-catenin ,Wnt ,CCL2 ,monocytes ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Isocitrate dehydrogenase (IDH)-wildtype glioblastoma (GBM) is a fast growing and highly heterogeneous tumor, often characterized by the presence of glioblastoma stem cells (GSCs). The plasticity of GSCs results in therapy resistance and impairs anti-tumor immune response by influencing immune cells in the tumor microenvironment (TME). Previously, β-catenin was associated with stemness in GBM as well as with immune escape mechanisms. Here, we investigated the effect of β-catenin on attracting monocytes towards GBM cells. In addition, we evaluated whether CCL2 is involved in β-catenin crosstalk between monocytes and tumor cells. Our analysis revealed that shRNA targeting β-catenin in GBMs reduces monocytes attraction and impacts CCL2 secretion. The addition of recombinant CCL2 restores peripheral blood mononuclear cells (PBMC) migration towards medium (TCM) conditioned by shβ-catenin GBM cells. CCL2 knockdown in GBM cells shows similar effects and reduces monocyte migration to a similar extent as β-catenin knockdown. When investigating the effect of CCL2 on β-catenin activity, we found that CCL2 modulates components of the Wnt/β-catenin pathway and alters the clonogenicity of GBM cells. In addition, the pharmacological β-catenin inhibitor MSAB reduces active β-catenin, downregulates the expression of associated genes and alters CCL2 secretion. Taken together, we showed that β-catenin plays an important role in attracting monocytes towards GBM cells in vitro. We hypothesize that the interactions between β-catenin and CCL2 contribute to maintenance of GSCs via modulating immune cell interaction and promoting GBM growth and recurrence.
- Published
- 2022
- Full Text
- View/download PDF
6. Obesity Has a Systemic Effect on Immune Cells in Naïve and Cancer-Bearing Mice
- Author
-
Silke Neumann, Katrin Campbell, Matthew J. Woodall, Meghan Evans, Andrew N. Clarkson, and Sarah L. Young
- Subjects
obesity ,breast cancer ,colorectal cancer ,myeloid cells ,tumour-infiltrating lymphocytes ,inflammation ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Obesity is a major risk factor for developing cancer, with obesity-induced immune changes and inflammation in breast (BC) and colorectal cancer (CRC) providing a potential link between the two. This study investigates systemic effects of obesity on adaptive and innate immune cells in healthy and tumour-bearing mice. Immune cells from lean and obese mice were phenotyped prior to implantation of either BC (C57mg and EO771.LMB) or CRC (MC38) cells as tumour models. Tumour growth rate, tumour-infiltrating lymphocytes (TIL) and peripheral blood immune cell populations were compared between obese and lean mice. In vitro studies showed that naïve obese mice had higher levels of myeloid cells in the bone marrow and bone marrow-derived dendritic cells expressed lower levels of activation markers compared to cells from their lean counterparts. In the tumour setting, BC tumours grew faster in obese mice than in lean mice and lower numbers of TILs as well as higher frequency of exhausted T cells were observed. Data from peripheral blood showed lower levels of myeloid cells in tumour-bearing obese mice. This study highlights that systemic changes to the immune system are relevant for tumour burden and provides a potential mechanism behind the effects of obesity on cancer development and progression in patients.
- Published
- 2021
- Full Text
- View/download PDF
7. The Delta-Subunit Selective GABAA Receptor Modulator, DS2, Improves Stroke Recovery via an Anti-inflammatory Mechanism
- Author
-
Silke Neumann, Lily Boothman-Burrell, Emma K. Gowing, Thomas A. Jacobsen, Philip K. Ahring, Sarah L. Young, Karin Sandager-Nielsen, and Andrew N. Clarkson
- Subjects
stroke ,inflammation ,GABA ,immune response ,neuroinflammation ,functional recovery ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Inflammatory processes are known to contribute to tissue damage in the central nervous system (CNS) across a broad range of neurological conditions, including stroke. Gamma amino butyric acid (GABA), the main inhibitory neurotransmitter in the CNS, has been implicated in modulating peripheral immune responses by acting on GABAA receptors on antigen-presenting cells and lymphocytes. Here, we investigated the effects and mechanism of action of the delta-selective compound, DS2, to improve stroke recovery and modulate inflammation. We report a decrease in nuclear factor (NF)-κB activation in innate immune cells over a concentration range in vitro. Following a photochemically induced motor cortex stroke, treatment with DS2 at 0.1 mg/kg from 1 h post-stroke significantly decreased circulating tumor necrosis factor (TNF)-α, interleukin (IL)-17, and IL-6 levels, reduced infarct size and improved motor function in mice. Free brain concentrations of DS2 were found to be lower than needed for robust modulation of central GABAA receptors and were not affected by the presence and absence of elacridar, an inhibitor of both P-glycoprotein and breast cancer resistance protein (BCRP). Finally, as DS2 appears to dampen peripheral immune activation and only shows limited brain exposure, we assessed the role of DS2 to promote functional recovery after stroke when administered from 3-days after the stroke. Treatment with DS2 from 3-days post-stroke improved motor function on the grid-walking, but not on the cylinder task. These data highlight the need to further develop subunit-selective compounds to better understand change in GABA receptor signaling pathways both centrally and peripherally. Importantly, we show that GABA compounds such as DS2 that only shows limited brain exposure can still afford significant protection and promote functional recovery most likely via modulation of peripheral immune cells and could be given as an adjunct treatment.
- Published
- 2019
- Full Text
- View/download PDF
8. Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective
- Author
-
Silke Neumann, Nicholas J. Shields, Thomas Balle, Mary Chebib, and Andrew N. Clarkson
- Subjects
stroke ,inflammation ,nicotinic ,nicotinic acetylcholine receptor agonist ,immune response ,myeloid cells ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Stroke is one of the leading causes of death and long-term disability, with limited treatment options available. Inflammation contributes to damage tissue in the central nervous system across a broad range of neuropathologies, including Alzheimer’s disease, pain, Schizophrenia, and stroke. While the immune system plays an important role in contributing to brain damage produced by ischemia, the damaged brain, in turn, can exert a powerful immune-suppressive effect that promotes infections and threatens the survival of stroke patients. Recently the cholinergic anti-inflammatory pathway, in particular its modulation using α7-nicotinic acetylcholine receptor (α7-nAChR) ligands, has shown potential as a strategy to dampen the inflammatory response and facilitate functional recovery in stroke patients. Here we discuss the current literature on stroke-induced inflammation and the effects of α7-nAChR modulators on innate immune cells.
- Published
- 2015
- Full Text
- View/download PDF
9. Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial–Mesenchymal Transition-Like Reprogramming
- Author
-
Julia Tsiampali, Silke Neumann, Beatriz Giesen, Katharina Koch, Donata Maciaczyk, Christoph Janiak, Daniel Hänggi, and Jaroslaw Maciaczyk
- Subjects
A3AR ,adenosine ,CD73 ,drug targets ,epithelial–mesenchymal transition ,glioblastoma ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
Glioblastoma (GBM) is the most aggressive malignant primary brain tumour in adulthood. Despite strong research efforts current treatment options have a limited impact on glioma stem-like cells (GSCs) which contribute to GBM formation, progression and chemoresistance. Invasive growth of GSCs is in part associated with epithelial–mesenchymal-like transition (EMT), a mechanism associated with CD73 in several cancers. Here, we show that CD73 regulates the EMT activator SNAIL1 and further investigate the role of enzymatic and non-enzymatic CD73 activity in GBM progression. Reduction of CD73 protein resulted in significant suppression of GSC viability, proliferation and clonogenicity, whereas CD73 enzymatic activity exhibited negative effects only on GSC invasion involving impaired downstream adenosine (ADO) signalling. Furthermore, application of phosphodiesterase inhibitor pentoxifylline, a potent immunomodulator, effectively inhibited ZEB1 and CD73 expression and significantly decreased viability, clonogenicity, and invasion of GSC in vitro cultures. Given the involvement of adenosine and A3 adenosine receptor in GSC invasion, we investigated the effect of the pharmacological inhibition of A3AR on GSC maintenance. Direct A3AR inhibition promoted apoptotic cell death and impaired the clonogenicity of GSC cultures. Taken together, our data indicate that CD73 is an exciting novel target in GBM therapy. Moreover, pharmacological interference, resulting in disturbed ADO signalling, provides new opportunities to innovate GBM therapy.
- Published
- 2020
- Full Text
- View/download PDF
10. Improved anti-tumor activity of a therapeutic melanoma vaccine through the use of the dual COX-2/5-LO inhibitor licofelone
- Author
-
Silke Neumann, Simon A Shirley, Roslyn A Kemp, and Sarah M Hook
- Subjects
Liposomes ,Melanoma ,cancer vaccine ,5-lipoxygenase ,COX-2 ,myeloid-derived suppressor cells ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Immune-suppressive cell populations impair anti-tumor immunity and can contribute to the failure of immune therapeutic approaches. We hypothesized that the non-steroidal anti-inflammatory drug (NSAID) licofelone, a dual COX-2/5-LO inhibitor, would improve therapeutic melanoma vaccination by reducing immune-suppressive cell populations. Therefore, licofelone was administered after tumor implantation, either alone or in combination with a peptide vaccine containing a long tyrosinase-related protein (TRP)2-peptide and the adjuvant α-galactosylceramide, all formulated into cationic liposomes. Mice immunized with the long-peptide vaccine and licofelone showed delayed tumor growth compared to mice given the vaccine alone. This protection was associated with a lower frequency of immature myeloid cells (IMCs) in the bone marrow (BM) and spleen of tumor-inoculated mice. When investigating the effect of licofelone on IMCs in vitro, we found that the prostaglandin E2-induced generation of IMCs was decreased in the presence of licofelone. Furthermore, pre-incubation of BM cells differentiated under IMC-inducing conditions with licofelone reduced the secretion of cytokines interleukin (IL)-10 and -6 upon LPS stimulation as compared to untreated cells. Interestingly, licofelone increased IL-6 and IL-10 secretion when administered after the LPS stimulus, demonstrating an environment-dependent effect of licofelone. Our findings support the use of licofelone to reduce tumor-promoting cell populations.
- Published
- 2016
- Full Text
- View/download PDF
11. Predicting chemical environments of bacteria from receptor signaling.
- Author
-
Diana Clausznitzer, Gabriele Micali, Silke Neumann, Victor Sourjik, and Robert G Endres
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Sensory systems have evolved to respond to input stimuli of certain statistical properties, and to reliably transmit this information through biochemical pathways. Hence, for an experimentally well-characterized sensory system, one ought to be able to extract valuable information about the statistics of the stimuli. Based on dose-response curves from in vivo fluorescence resonance energy transfer (FRET) experiments of the bacterial chemotaxis sensory system, we predict the chemical gradients chemotactic Escherichia coli cells typically encounter in their natural environment. To predict average gradients cells experience, we revaluate the phenomenological Weber's law and its generalizations to the Weber-Fechner law and fold-change detection. To obtain full distributions of gradients we use information theory and simulations, considering limitations of information transmission from both cell-external and internal noise. We identify broad distributions of exponential gradients, which lead to log-normal stimuli and maximal drift velocity. Our results thus provide a first step towards deciphering the chemical nature of complex, experimentally inaccessible cellular microenvironments, such as the human intestine.
- Published
- 2014
- Full Text
- View/download PDF
12. Exponential signaling gain at the receptor level enhances signal-to-noise ratio in bacterial chemotaxis.
- Author
-
Silke Neumann, Linda Løvdok, Kajetan Bentele, Johannes Meisig, Ekkehard Ullner, Ferencz S Paldy, Victor Sourjik, and Markus Kollmann
- Subjects
Medicine ,Science - Abstract
Cellular signaling systems show astonishing precision in their response to external stimuli despite strong fluctuations in the molecular components that determine pathway activity. To control the effects of noise on signaling most efficiently, living cells employ compensatory mechanisms that reach from simple negative feedback loops to robustly designed signaling architectures. Here, we report on a novel control mechanism that allows living cells to keep precision in their signaling characteristics - stationary pathway output, response amplitude, and relaxation time - in the presence of strong intracellular perturbations. The concept relies on the surprising fact that for systems showing perfect adaptation an exponential signal amplification at the receptor level suffices to eliminate slowly varying multiplicative noise. To show this mechanism at work in living systems, we quantified the response dynamics of the E. coli chemotaxis network after genetically perturbing the information flux between upstream and downstream signaling components. We give strong evidence that this signaling system results in dynamic invariance of the activated response regulator against multiplicative intracellular noise. We further demonstrate that for environmental conditions, for which precision in chemosensing is crucial, the invariant response behavior results in highest chemotactic efficiency. Our results resolve several puzzling features of the chemotaxis pathway that are widely conserved across prokaryotes but so far could not be attributed any functional role.
- Published
- 2014
- Full Text
- View/download PDF
13. Imprecision of adaptation in Escherichia coli chemotaxis.
- Author
-
Silke Neumann, Nikita Vladimirov, Anna K Krembel, Ned S Wingreen, and Victor Sourjik
- Subjects
Medicine ,Science - Abstract
Adaptability is an essential property of many sensory systems, enabling maintenance of a sensitive response over a range of background stimulus levels. In bacterial chemotaxis, adaptation to the preset level of pathway activity is achieved through an integral feedback mechanism based on activity-dependent methylation of chemoreceptors. It has been argued that this architecture ensures precise and robust adaptation regardless of the ambient ligand concentration, making perfect adaptation a celebrated property of the chemotaxis system. However, possible deviations from such ideal adaptive behavior and its consequences for chemotaxis have not been explored in detail. Here we show that the chemotaxis pathway in Escherichia coli shows increasingly imprecise adaptation to higher concentrations of attractants, with a clear correlation between the time of adaptation to a step-like stimulus and the extent of imprecision. Our analysis suggests that this imprecision results from a gradual saturation of receptor methylation sites at high levels of stimulation, which prevents full recovery of the pathway activity by violating the conditions required for precise adaptation. We further use computer simulations to show that limited imprecision of adaptation has little effect on the rate of chemotactic drift of a bacterial population in gradients, but hinders precise accumulation at the peak of the gradient. Finally, we show that for two major chemoeffectors, serine and cysteine, failure of adaptation at concentrations above 1 mM might prevent bacteria from accumulating at toxic concentrations of these amino acids.
- Published
- 2014
- Full Text
- View/download PDF
14. Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients
- Author
-
Maria J.G.T. Vehreschild, Arne M.K. Meißner, Oliver Andreas Cornely, Georg Maschmeyer, Silke Neumann, Marie von Lilienfeld-Toal, Meinholf Karthaus, Mohammed Wattad, Peter Staib, Martin Hellmich, Hildegard Christ, and Jörg Janne Vehreschild
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
Background Neutropenic patients are at risk of abdominal complications and yet the incidence and impact of these complications on patients’ morbidity and mortality have not been sufficiently evaluated. We aimed to assess a clinical rule for early detection of abdominal complications leading to death or transfer to intensive care in patients with chemotherapy-associated neutropenia.Design and Methods This observational multicenter study was carried out in seven German hematology-oncology departments. For inclusion, neutropenia of at least 5 consecutive days was required. Risk factors for “transfer to intensive care” and “death” were assessed by backward-stepwise binary logistic regression analyses. Chemotherapy-associated bowel syndrome was defined as a combination of fever (T ≥37.8 °C) and abdominal pain and/or lack of bowel movement for 72 hours or more. Five hundred and twenty-one neutropenic episodes were documented in 359 patients.Results The incidence of chemotherapy-associated bowel syndrome was 126/359 (35%) in first episodes of neutropenia. Transfer to intensive care occurred in 41/359 (11%) and death occurred in 17/359 (5%) first episodes. Chemotherapy-associated bowel syndrome and duration of neutropenia were identified as risk factors for transfer to intensive care (P
- Published
- 2011
- Full Text
- View/download PDF
15. Atlas - Examining the Wider Context of Assistive Robotics.
- Author
-
Hans Dermot Doran, Silke Neumann, Heidrun Karin Becker, Anja Kollmar, Sabina Misoch, Cora Pauli, Salome Müller, and Frank Hannich
- Published
- 2018
- Full Text
- View/download PDF
16. Calpains Released from Necrotic Tumor Cells Enhance Antigen Cross-Presentation to Activate CD8+ T Cells In Vitro
- Author
-
Nicholas J. Shields, Estelle M. Peyroux, Katrin Campbell, Sunali Mehta, Adele G. Woolley, Claudio Counoupas, Silke Neumann, and Sarah L. Young
- Subjects
Immunology ,Immunology and Allergy - Abstract
The initiation of CD8+ T cell responses against dead cell–associated Ags is tightly regulated, facilitating adaptive immunity against pathogens and tumors while preventing autoimmunity. It is now well established that dying cells actively regulate the generation of CD8+ T cell responses via the release or exposure of damage-associated molecular patterns. However, it is unclear whether nonproteasomal proteases (activated in stressed and dying cells) can influence the availability of Ags for cross-presentation. Using a mouse model of immunogenic necrosis, we investigated the role of tumor-derived proteases in the priming of CD8+ T cells. We demonstrate that proteases released from necrotic tumor cells can degrade whole-protein Ag, generating proteolytic intermediates that are efficiently cross-presented by dendritic cells and enhance CD8+ T cell cross-priming. We identify a dominant role for calpain proteases, which are activated during necrotic cell death induced by severe heat shock. Mechanistically, proteolytic intermediates generated by tumor-derived proteases associate with necrotic tumor cell debris, which acts as a vehicle for Ag transfer that facilitates highly efficient cross-presentation in dendritic cells. Our results suggest that proteolytic systems activated in Ag donor cells during cell death may influence the availability of antigenic substrates for cross-presentation, thereby regulating the antigenicity of cell death.
- Published
- 2022
17. Example of the application of the PERSONA methodology in the definition of needs and requirements for the WeTakeCare system.
- Author
-
Ricard Barberà-Guillem, Rakel Poveda-Puente, Silke Neumann, Heidrun Becker, Miguel Ramírez, Arno Wienholtz, and Inge Schaedler
- Published
- 2015
- Full Text
- View/download PDF
18. WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells
- Author
-
Suad Yusuf, Philippe Aretz, Ann-Christin Nickel, Philipp Westhoff, Amit Sharma, Nan Qin, Marc Remke, Hans-Jakob Steiger, Daniel Hänggi, Hongjia Liu, Hongde Liu, Silke Neumann, Guido Reifenberger, and Jarek Maciaczyk
- Subjects
glioblastoma ,cancer stem-like cells ,glucose starvation ,cancer metabolism ,WNT/β-catenin ,Cancer Research ,Oncology - Abstract
Isocitrate dehydrogenase (IDH)-wildtype glioblastoma is the most common primary malignant brain tumor. It is associated with a particularly poor prognosis, as reflected by an overall median survival of only 15 months in patients who undergo a supramarginal surgical reduction of the tumor mass followed by combined chemoradiotherapy. The highly malignant nature of IDH-wildtype glioblastoma is thought to be driven by glioblastoma stem-like cells (GSCs) that harbor the ability of self-renewal, survival, and adaptability to challenging environmental conditions. The wingless (WNT) signaling pathway is a phylogenetically highly conserved stemness pathway, which promotes metabolic plasticity and adaptation to a nutrient-limited tumor microenvironment. To unravel the reciprocal regulation of the WNT pathway and the nutrient-limited microenvironment, glioblastoma cancer stem-like cells were cultured in a medium with either standard or reduced glucose concentrations for various time points (24, 48, and 72 h). Glucose depletion reduced cell viability and facilitated the survival of a small population of starvation-resistant tumor cells. The surviving cells demonstrated increased clonogenic and invasive properties as well as enhanced chemosensitivity to pharmacological inhibitors of the WNT pathway (LGK974, berberine). Glucose depletion partially led to the upregulation of WNT target genes such as CTNNB1, ZEB1, and AXIN2 at the mRNA and corresponding protein levels. LGK974 treatment alone or in combination with glucose depletion also altered the metabolite concentration in intracellular compartments, suggesting WNT-mediated metabolic regulation. Taken together, our findings suggest that WNT-mediated metabolic plasticity modulates the survival of GSCs under nutrient-restricted environmental conditions.
- Published
- 2022
- Full Text
- View/download PDF
19. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
- Author
-
Karin Mayer, Silke Neumann, Hans-Heinrich Wolf, Luisa Durán Graeff, Michael Sandherr, Annika Y. Classen, Stefan W. Krause, Larissa Henze, Olaf Penack, Maximilian Christopeit, Georg Maschmeyer, Jörg Janne Vehreschild, Nael Alakel, Oliver A. Cornely, Marie von Lilienfeld-Toal, and Florian Weißinger
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Neutropenia ,medicine.medical_treatment ,Resistance ,030106 microbiology ,Antineoplastic Agents ,Pcp prophylaxis ,Medical Oncology ,Pneumocystis carinii ,03 medical and health sciences ,0302 clinical medicine ,Bacterial infections ,Germany ,Internal medicine ,Drug Resistance, Bacterial ,medicine ,Humans ,In patient ,ddc:610 ,Societies, Medical ,Hematology ,Prophylaxis ,Pneumocystis ,business.industry ,Microbiota ,Pneumonia, Pneumocystis ,Pneumocystis jirovecii Pneumonia ,Cancer ,Immunosuppression ,General Medicine ,Guideline ,medicine.disease ,Anti-Bacterial Agents ,Hematologic Neoplasms ,030220 oncology & carcinogenesis ,Original Article ,business ,Fluoroquinolones - Abstract
Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections and Pneumocystis jirovecii pneumonia (PcP). As bacterial resistances are increasing worldwide and new research reshapes our understanding of the interactions between the human host and bacterial commensals, administration of antibacterial prophylaxis has become a matter of discussion. This guideline constitutes an update of the 2013 published guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). It gives an overview about current strategies for antibacterial prophylaxis in cancer patients while taking into account the impact of antibacterial prophylaxis on the human microbiome and resistance development. Current literature published from January 2012 to August 2020 was searched and evidence-based recommendations were developed by an expert panel. All recommendations were discussed and approved in a consensus conference of the AGIHO prior to publication. As a result, we present a comprehensive update and extension of our guideline for antibacterial and PcP prophylaxis in cancer patients. Supplementary Information The online version contains supplementary material available at 10.1007/s00277-021-04452-9.
- Published
- 2021
20. Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial
- Author
-
Silke Neumann, Andrew N Reynolds, Jim Mann, Sebastian Åberg, and Alastair B. Ross
- Subjects
Blood Glucose ,Male ,Food Handling ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Glycemic Control ,Type 2 diabetes ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Animal science ,Randomized controlled trial ,law ,Diabetes mellitus ,Blood Glucose Self-Monitoring ,Internal Medicine ,medicine ,Humans ,030212 general & internal medicine ,Meals ,Triticum ,Aged ,Breakfast ,Glycemic ,Advanced and Specialized Nursing ,Whole Grains ,Cross-Over Studies ,business.industry ,Clinical Care/Education/Nutrition/Psychosocial Research ,food and beverages ,Middle Aged ,Postprandial Period ,medicine.disease ,Crossover study ,Postprandial ,Diabetes Mellitus, Type 2 ,Female ,Brown rice ,Energy Intake ,business ,New Zealand - Abstract
OBJECTIVE To consider the effects of whole-grain processing, specifically milling, on glycemic control in free-living adults with type 2 diabetes. RESEARCH DESIGN AND METHODS Participants of this crossover trial were randomized to two interventions of 2 weeks, separated by washout. They were advised to replace the grain foods they normally consumed with intervention foods. Intervention foods were nutrient-matched whole-grain products of wheat, oats, and brown rice that differed in their degree of processing. No other lifestyle advice was given. Continuous glucose monitoring systems were worn. Other cardiometabolic risk factors and alkylresorcinols (a biomarker of whole-grain intake) were measured pre- and postintervention. RESULTS Thirty-one adults with type 2 diabetes (63 ± 13 years old, BMI 32.4 ± 7 kg/m2, HbA1c 7.5 ± 3.4% [59 ± 14 mmol/mol]) commenced the trial; 28 (90%) completed both interventions. The increase in alkylresorcinols did not differ between interventions, and there was no difference in reported energy intake. Postprandial responses were 9% (95% CI 3–15) lower following breakfast and 6% (1–10) lower following all meals of less-processed whole grains when compared with finely milled grains. Day-long glycemic variability also was reduced when measured by 24-h SD (−0.16 mmol/L [95% CI −0.25 to −0.06]) and mean amplitude of glycemic excursion (−0.36 [95% CI −0.65 to −0.08]). Mean change in body weight differed by 0.81 kg (95% CI 0.62–1.05) between interventions, increasing during the finely milled intervention and decreasing during the less-processed whole-grain intervention. This was not a mediating factor for the glycemic variables considered. CONCLUSIONS Consuming less-processed whole-grain foods over 2 weeks improved measures of glycemia in free-living adults with type 2 diabetes compared with an equivalent amount of whole-grain foods that were finely milled. Dietary advice should promote the consumption of minimally processed whole grains.
- Published
- 2020
21. Silke Neumann und die BUREAU N GmbH
- Author
-
Uwe Rössler and Silke Neumann
- Published
- 2022
22. Kulturkommunikation / Cultural Communication
- Author
-
Silke Neumann
- Subjects
Cultural communication ,Media studies ,Sociology - Published
- 2021
23. Calpains Released from Necrotic Tumor Cells Enhance Antigen Cross-Presentation to Activate CD8
- Author
-
Nicholas J, Shields, Estelle M, Peyroux, Katrin, Campbell, Sunali, Mehta, Adele G, Woolley, Claudio, Counoupas, Silke, Neumann, and Sarah L, Young
- Subjects
Antigen Presentation ,Necrosis ,Cross-Priming ,Calpain ,Neoplasms ,Humans ,Dendritic Cells ,CD8-Positive T-Lymphocytes - Abstract
The initiation of CD8
- Published
- 2021
24. Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial–Mesenchymal Transition-Like Reprogramming
- Author
-
Daniel Hänggi, Christoph Janiak, Donata Maciaczyk, Silke Neumann, Katharina Koch, Beatriz Giesen, Julia Tsiampali, and Jaroslaw Maciaczyk
- Subjects
0301 basic medicine ,endocrine system ,Pharmaceutical Science ,lcsh:Medicine ,lcsh:RS1-441 ,epithelial–mesenchymal transition ,Article ,Pentoxifylline ,lcsh:Pharmacy and materia medica ,03 medical and health sciences ,0302 clinical medicine ,Glioma ,Drug Discovery ,drug targets ,medicine ,Epithelial–mesenchymal transition ,Phosphodiesterase inhibitor ,Activator (genetics) ,Chemistry ,fungi ,lcsh:R ,glioblastoma ,medicine.disease ,Adenosine ,In vitro ,nervous system diseases ,030104 developmental biology ,adenosine ,030220 oncology & carcinogenesis ,Cancer research ,CD73 ,Molecular Medicine ,A3AR ,Reprogramming ,medicine.drug - Abstract
Glioblastoma (GBM) is the most aggressive malignant primary brain tumour in adulthood. Despite strong research efforts current treatment options have a limited impact on glioma stem-like cells (GSCs) which contribute to GBM formation, progression and chemoresistance. Invasive growth of GSCs is in part associated with epithelial&ndash, mesenchymal-like transition (EMT), a mechanism associated with CD73 in several cancers. Here, we show that CD73 regulates the EMT activator SNAIL1 and further investigate the role of enzymatic and non-enzymatic CD73 activity in GBM progression. Reduction of CD73 protein resulted in significant suppression of GSC viability, proliferation and clonogenicity, whereas CD73 enzymatic activity exhibited negative effects only on GSC invasion involving impaired downstream adenosine (ADO) signalling. Furthermore, application of phosphodiesterase inhibitor pentoxifylline, a potent immunomodulator, effectively inhibited ZEB1 and CD73 expression and significantly decreased viability, clonogenicity, and invasion of GSC in vitro cultures. Given the involvement of adenosine and A3 adenosine receptor in GSC invasion, we investigated the effect of the pharmacological inhibition of A3AR on GSC maintenance. Direct A3AR inhibition promoted apoptotic cell death and impaired the clonogenicity of GSC cultures. Taken together, our data indicate that CD73 is an exciting novel target in GBM therapy. Moreover, pharmacological interference, resulting in disturbed ADO signalling, provides new opportunities to innovate GBM therapy.
- Published
- 2020
25. The Influence of Microbial Metabolites in the Gastrointestinal Microenvironment on Anticancer Immunity
- Author
-
Matt J. Woodall, Nick J. Shields, Estelle M. Peyroux, Sharon Pattison, Sarah L. Young, and Silke Neumann
- Subjects
Anticancer immunity ,Cancer research ,Biology - Published
- 2020
26. Wholegrain processing and glycaemic control in type 2 diabetes: a randomised crossover trial
- Author
-
Andrew N Reynolds, Alastair B Ross, Silke Neumann, Jim Mann, and Sebastian Åberg
- Abstract
Objective: To consider the effects of wholegrain processing, specifically milling, on glycaemic control in free-living adults with type 2 diabetes. Research Design and Methods: Participants of this crossover trial were randomised to two interventions of two-weeks, separated by washout. They were advised to replace the grain foods they normally consumed with intervention foods. Intervention foods were nutrient matched wholegrain products of wheat, oats, and brown rice that differed in their degree of processing. No other lifestyle advice was given. Continuous glucose monitoring systems were worn. Other cardiometabolic risk factors and alkylresorcinols (a biomarker of wholegrain intake) were measured pre and post interventions. Results: 31 adults with type 2 diabetes (63±13 years old, BMI 32.4±7, HbA1c 7.5±3.4% (59±14mmol/mol)) commenced the trial, 28 (90%) completed both interventions. The increase in alkylresorcinols did not differ between interventions and there was no difference in reported energy intake. Postprandial responses were 9% (95%CI 3-15%) lower following breakfast and 6% (95%CI 1-10%) lower following all meals of less processed whole grains when compared with finely milled grains. Day-long glycaemic variability also reduced when measured by 24-hour standard deviation (-0.16mmol/l 95%CI -0.25 to -0.06) and MAGE (-0.36 95%CI -0.65 to -0.08). Mean change in body weight differed by 0.81kg (95%CI 0.62 to 1.05) between interventions, increasing during the finely milled intervention and decreasing during the less processed wholegrain intervention. This was not a mediating factor for the glycaemic variables considered. Conclusions: Consuming less processed wholegrain foods over two weeks improved measures of glycaemia in free-living adults with type 2 diabetes when compared with an equivalent amount of wholegrain foods that were finely milled. Dietary advice should promote the consumption of minimally processed whole grains.
- Published
- 2020
27. The Effects of Obesity on Anti-Cancer Immunity and Cancer Immunotherapy
- Author
-
Matthew J Woodall, Sharon Pattison, Katrin Campbell, Sarah L. Young, and Silke Neumann
- Subjects
0301 basic medicine ,Cancer Research ,obesity ,medicine.medical_treatment ,Inflammation ,Review ,Bioinformatics ,lcsh:RC254-282 ,metabolic syndrome ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Cancer immunotherapy ,T-cell exhaustion ,medicine ,cancer ,business.industry ,Cancer ,Immunotherapy ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Immune checkpoint ,Radiation therapy ,030104 developmental biology ,Oncology ,checkpoint therapy ,inflammation ,030220 oncology & carcinogenesis ,immunotherapy ,medicine.symptom ,Metabolic syndrome ,business - Abstract
Cancer is one of the leading causes of morbidity and mortality worldwide. Traditional treatments include surgery, chemotherapy and radiation therapy, and more recently targeted therapies including immunotherapy are becoming routine care for some cancers. Immunotherapy aims to upregulate the patient’s own immune system, enabling it to destroy cancerous cells. Obesity is a metabolic disorder characterized by significant weight that is an important contributor to many different diseases, including cancers. Obesity impacts the immune system and causes, among other things, a state of chronic low-grade inflammation. This is hypothesized to impact the efficacy of the immunotherapies. This review discusses the effects of obesity on the immune system and cancer immunotherapy, including the current evidence on the effect of obesity on immune checkpoint blockade, something which currently published reviews on this topic have not delved into. Data from several studies show that even though obesity causes a state of chronic low-grade inflammation with reductions in effector immune populations, it has a beneficial effect on patient survival following anti-PD-1/PD-L1 and anti-CTLA-4 treatment. However, research in this field is just emerging and further work is needed to expand our understanding of which cancer patients are likely to benefit from immunotherapy.
- Published
- 2020
28. Silke Neumann und das BUREAU N
- Author
-
Uwe Rössler and Silke Neumann
- Abstract
Im Jahr 2008 grundet Silke Neumann die Agentur fur Kulturkommunikation Bureau N. Die Zeit fur eine Unternehmensgrundung ist gunstig. Der Berliner Kunstmarkt befindet sich im Umbruch. Kunst, Kultur und Kreativitat gehoren zu den Wachstumsmotoren der Berliner Wirtschaft und werden zu Markenzeichen der Stadt (Senatsverwaltung fur Wirtschaft, Energie und Betriebe 2014). Kunstler, Galerien und Kulturschaffende zieht es nach Berlin, sie suchen nach Vernetzung und Profilierung. Beides kann Bureau N anbieten. Mit zunehmender Bekanntheit wachst das Unternehmen auch in andere Aufgaben und Geschaftsfelder hinein und entwickelt heute Kommunikationskonzepte und Markenstrategien fur die Kreativwirtschaft.
- Published
- 2020
29. The Corona Cookbook
- Author
-
Lena Mahr, Markus Miessen, Silvia Liebrich, Leeza Ahmady, Anne Ameri-Siemens, Many Ameri, Armen Avanessian, Nancy Bachmann, Denise Booth, Kimberly Bradley, Telse Bus, Elio Caccavale, Melanie dal Canton, Laura Catania, Marta Cavallé, Yann Chateigné, Marijana Condic, Oskar Melzer, Celine Condorelli, Diandra Donecker, Anne Ellinghaus, Irmgard Emmelhainz, Timo Feldhaus, Jesko Fezer, Sarah M. Fischer, Carsten Fröhlich, Henriette Gallus, Martino Gamper, Crystal Gillette, Lukas Mahr, Maaike Gouwenberg, Isabelle Graeff, Flaka Haliti, Philipp Nitsche, Harriet Harriss, Kristin Heil, Nele Heinevetter, Sonja Heiss, Lizzy Herold, Patrick Herold, Samantha Hookway, Mavie Hörbiger, Paul Feigelfeld, Rafael Horzon, Ike Ikrath, Evelyn Ikrath, Sarah Illenberger, Christina Jagla, Marisa Mazria Katz, Susanne Kriemann, Lukas Kubina, Prem Krishnamurthy, Zhen Kueh, Matylda Krzykowski, Zak Kyes, Patrick Lacey, Alanna Lawley, Pierre Jorge Gonzales, Eliza Mahr, Jonas Mahr, Jens Maier-Rothe, Chus Martinez, Nina Mentrup, Jens Mentrup, Kate Merritt, Milly Miessen, Jake Matatyaou, Nina Möntmann, Angus Morton, Marianne Müller, Olaf Kneer, Lina Muzur, Christian Werner, Reiko Nakamura, Silke Neumann, Michelle Nicol, Hans Ulrich Obrist, Jonathan Olivares, Badia Ouahi, Erica Overmeer, Henriette Pleiger, Philip Pocock, Barbara K. Prokop, Laura Raicovich, Tobias Rehberger, Sarah Rifky, Bryony Roberts, Judith Rooze, Samuel Taylor, Lisa Rosendahl, Andreas Rumpfhuber, Olympia Samara, Johannes Hoffmann, Micha Schäfer, Eva Scharrer, Stephanie Schleipen, Florian Schramm, Elena Schütz, Julian Schubert, Ina Seifart, Judith Seng, Alex Valder, Carl von Siemens, Toni Spencer, Johanna Slotawa, Florian Slotawa, Julia Stoschek, Jenna Sutela, Alia Swastika, Sally Tallant, Boris Tanaka, Benedicte Thoraval, Stephanie Tscheppe-Eselböck, Eduard Tscheppe-Eselböck, Jeanne Tremsal, Christopher Roth, Stefanos Tsivopoulos, Max Vallot, Lua Vollaard, Nick Axel, Joanna Warsza, Marta Nowicka, Amy Watson, Nina Wesemann, David Benedek, Elliot White, Nicholas Wolken, Billy Wagner, Lena Mahr, Markus Miessen, Silvia Liebrich, Leeza Ahmady, Anne Ameri-Siemens, Many Ameri, Armen Avanessian, Nancy Bachmann, Denise Booth, Kimberly Bradley, Telse Bus, Elio Caccavale, Melanie dal Canton, Laura Catania, Marta Cavallé, Yann Chateigné, Marijana Condic, Oskar Melzer, Celine Condorelli, Diandra Donecker, Anne Ellinghaus, Irmgard Emmelhainz, Timo Feldhaus, Jesko Fezer, Sarah M. Fischer, Carsten Fröhlich, Henriette Gallus, Martino Gamper, Crystal Gillette, Lukas Mahr, Maaike Gouwenberg, Isabelle Graeff, Flaka Haliti, Philipp Nitsche, Harriet Harriss, Kristin Heil, Nele Heinevetter, Sonja Heiss, Lizzy Herold, Patrick Herold, Samantha Hookway, Mavie Hörbiger, Paul Feigelfeld, Rafael Horzon, Ike Ikrath, Evelyn Ikrath, Sarah Illenberger, Christina Jagla, Marisa Mazria Katz, Susanne Kriemann, Lukas Kubina, Prem Krishnamurthy, Zhen Kueh, Matylda Krzykowski, Zak Kyes, Patrick Lacey, Alanna Lawley, Pierre Jorge Gonzales, Eliza Mahr, Jonas Mahr, Jens Maier-Rothe, Chus Martinez, Nina Mentrup, Jens Mentrup, Kate Merritt, Milly Miessen, Jake Matatyaou, Nina Möntmann, Angus Morton, Marianne Müller, Olaf Kneer, Lina Muzur, Christian Werner, Reiko Nakamura, Silke Neumann, Michelle Nicol, Hans Ulrich Obrist, Jonathan Olivares, Badia Ouahi, Erica Overmeer, Henriette Pleiger, Philip Pocock, Barbara K. Prokop, Laura Raicovich, Tobias Rehberger, Sarah Rifky, Bryony Roberts, Judith Rooze, Samuel Taylor, Lisa Rosendahl, Andreas Rumpfhuber, Olympia Samara, Johannes Hoffmann, Micha Schäfer, Eva Scharrer, Stephanie Schleipen, Florian Schramm, Elena Schütz, Julian Schubert, Ina Seifart, Judith Seng, Alex Valder, Carl von Siemens, Toni Spencer, Johanna Slotawa, Florian Slotawa, Julia Stoschek, Jenna Sutela, Alia Swastika, Sally Tallant, Boris Tanaka, Benedicte Thoraval, Stephanie Tscheppe-Eselböck, Eduard Tscheppe-Eselböck, Jeanne Tremsal, Christopher Roth, Stefanos Tsivopoulos, Max Vallot, Lua Vollaard, Nick Axel, Joanna Warsza, Marta Nowicka, Amy Watson, Nina Wesemann, David Benedek, Elliot White, Nicholas Wolken, and Billy Wagner
- Abstract
This document in front of you is the result of a conversation over lunch, which took place in the early days of Corona in Berlin. Back then, we were simply wondering: in a time in which people are, either by policy or good faith, forced to restrict their spatial radius of interaction to a bare minimum, how do we actually deal with food? Not only in the sense of what we choose to eat conceptually, but how we choose it, literally. Where do we get it, how do we prepare it, and what does something essential like food mean to us in times of crisis?, https://www.librarystack.org/corona-cookbook-the/?ref=unknown
- Published
- 2020
30. Acute or Delayed Systemic Administration of Human Amnion Epithelial Cells Improves Outcomes in Experimental Stroke
- Author
-
Silke Neumann, Megan A Evans, Kimberly W.E. Taylor, Emma K. Gowing, Andrew N. Clarkson, Leon Teo, Hannah X Chu, Chantelle V. Gardiner-Mann, Velandai Srikanth, Sarah L. Young, David Y. Fann, William C. Kwan, Thanh G. Phan, Euan M. Wallace, Thiruma V. Arumugam, Grant R Drummond, Brad R.S. Broughton, Hyun Ah Kim, Vanessa H Brait, John M. Haynes, Rebecca Lim, Stavros Selemidis, Christopher G. Sobey, Quynh Nhu Dinh, Christopher T. Chan, Colin W. Pouton, Cameron P.J. Hunt, Luting Poh, Seyoung Lee, Antony Vinh, Henry Ma, and James A. Bourne
- Subjects
Male ,0301 basic medicine ,Ischemia ,Inflammation ,Pharmacology ,Neuroprotection ,Brain ischemia ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Animals ,Humans ,Medicine ,Amnion ,CXC chemokine receptors ,Stroke ,Advanced and Specialized Nursing ,business.industry ,Cerebral infarction ,Callithrix ,Epithelial Cells ,medicine.disease ,Disease Models, Animal ,030104 developmental biology ,Systemic administration ,Heterografts ,Female ,Neurology (clinical) ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,030217 neurology & neurosurgery - Abstract
Background and Purpose— Human amnion epithelial cells (hAECs) are nonimmunogenic, nontumorigenic, anti-inflammatory cells normally discarded with placental tissue. We reasoned that their profile of biological features, wide availability, and the lack of ethical barriers to their use could make these cells useful as a therapy in ischemic stroke. Methods— We tested the efficacy of acute (1.5 hours) or delayed (1–3 days) poststroke intravenous injection of hAECs in 4 established animal models of cerebral ischemia. Animals included young (7–14 weeks) and aged mice (20–22 months) of both sexes, as well as adult marmosets of either sex. Results— We found that hAECs administered 1.5 hours after stroke in mice migrated to the ischemic brain via a CXC chemokine receptor type 4-dependent mechanism and reduced brain inflammation, infarct development, and functional deficits. Furthermore, if hAECs administration was delayed until 1 or 3 days poststroke, long-term functional recovery was still augmented in young and aged mice of both sexes. We also showed proof-of-principle evidence in marmosets that acute intravenous injection of hAECs prevented infarct development from day 1 to day 10 after stroke. Conclusions— Systemic poststroke administration of hAECs elicits marked neuroprotection and facilitates mechanisms of repair and recovery.
- Published
- 2018
31. The Influence of Microbial Metabolites in the Gastrointestinal Microenvironment on Anticancer Immunity
- Author
-
Silke, Neumann, M., Peyroux, Estelle, J., Woodall, Matt, J., Shields, Nick, L., Young, Sarah, and T., Pattison, Sharon
- Subjects
InformationSystems_INFORMATIONSTORAGEANDRETRIEVAL ,GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries) - Published
- 2019
32. Molecular monitoring of glioblastoma’s immunogenicity using a combination of Raman spectroscopy and chemometrics
- Author
-
Julia Tsiampali, Silke Neumann, Donata Maciaczyk, Jaroslaw Maciaczyk, Sara J. Fraser-Miller, Keith C. Gordon, Sarah L. Young, and Chima Robert
- Subjects
Support Vector Machine ,Population ,02 engineering and technology ,Spectrum Analysis, Raman ,010402 general chemistry ,01 natural sciences ,Analytical Chemistry ,Chemometrics ,symbols.namesake ,Immune system ,medicine ,Humans ,education ,Instrumentation ,Spectroscopy ,Principal Component Analysis ,education.field_of_study ,Chemistry ,Monocyte ,Immunogenicity ,Discriminant Analysis ,021001 nanoscience & nanotechnology ,Phenotype ,Molecular biology ,Atomic and Molecular Physics, and Optics ,0104 chemical sciences ,medicine.anatomical_structure ,Monocyte differentiation ,symbols ,Glioblastoma ,0210 nano-technology ,Raman spectroscopy - Abstract
Raman spectroscopy (RS) has been used as a powerful diagnostic and non-invasive tool in cancer diagnosis as well as in discrimination of cancer and immune cells. In this study RS in combination with chemometrics was applied to cellular Raman spectral data to distinguish the phenotype of T-cells and monocytes after incubation with media conditioned by glioblastoma stem-cells (GSCs) showing different molecular background. For this purpose, genetic modulations of epithelial-to-mesenchymal transition (EMT) process and expression of immunomodulator CD73 were introduced. Principal component analysis of the Raman spectral data showed that T-cells and monocytes incubated with tumour-conditioned media (TCMs) of GSCs with inhibited EMT activator ZEB1 or CD73 formed distinct clusters compared to controls highlighting their differences. Further discriminatory analysis performed using linear discriminant analysis (LDA) and support vector machine classification (SVM), yielded sensitivities and specificities of over 70 and 67% respectively upon validation against an independent test set. Supporting those results, flow cytometric analysis was performed to test the influence of TCMs on cytokine profile of T-cells and monocytes. We found that ZEB1 and CD73 influence T-cell and monocyte phenotype and promote monocyte differentiation into a population of mixed pro- and anti-tumorigenic macrophages (MΦs) and dendritic cells (DCs) respectively. In conclusion, Raman spectroscopy in combination with chemometrics enabled tracking T-cells and monocytes.
- Published
- 2021
33. Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation
- Author
-
Yunji Zheng, Andreas Wieser, Anna Waldhuber, Catharina Svanborg, Silke Neumann-Pfeifer, Simone Albrecht, Franziska Römmler, Sören Schubert, Manoj Puthia, Christine Cirl, Tina Müller, Olaf Groß, Susanne Dürr, and Thomas Miethke
- Subjects
0301 basic medicine ,Inflammasomes ,Virulence Factors ,Interleukin-1beta ,Virulence ,Bone Marrow Cells ,Biology ,urologic and male genital diseases ,medicine.disease_cause ,Virulence factor ,Microbiology ,Mice ,03 medical and health sciences ,Cytosol ,Immune system ,Protein Domains ,Immunity ,NLR Family, Pyrin Domain-Containing 3 Protein ,medicine ,Animals ,Humans ,Uropathogenic Escherichia coli ,Secretion ,Escherichia coli ,Innate immune system ,Escherichia coli Proteins ,Macrophages ,Caspase 1 ,Inflammasome ,General Medicine ,Immunity, Innate ,Mice, Inbred C57BL ,HEK293 Cells ,030104 developmental biology ,Urinary Tract Infections ,Female ,Research Article ,medicine.drug - Abstract
Successful bacterial pathogens produce an array of virulence factors that allow subversion of the immune system and persistence within the host. For example, uropathogenic Escherichia coli strains, such as CFT073, express Toll/IL-1 receptor-containing (TIR-containing) protein C (TcpC), which impairs TLR signaling, thereby suppressing innate immunity in the urinary tract and enhancing persistence in the kidneys. Here, we have reported that TcpC also reduces secretion of IL-1β by directly interacting with the NACHT leucin-rich repeat PYD protein 3 (NLRP3) inflammasome, which is crucial for recognition of pathogens within the cytosol. At a low MOI, IL-1β secretion was minimal in CFT073-infected macrophages; however, IL-1β release was markedly increased in macrophages infected with CFT073 lacking tcpC. Induction of IL-1β secretion by CFT073 and tcpC-deficient CFT073 required the NLRP3 inflammasome. TcpC attenuated activation of the NLRP3 inflammasome by binding both NLRP3 and caspase-1 and thereby preventing processing and activation of caspase-1. Moreover, in a murine urinary tract infection model, CFT073 infection rapidly induced expression of the NLRP3 inflammasome in the bladder mucosa; however, the presence of TcpC in WT CFT073 reduced IL-1β levels in the urine of infected mice. Together, these findings illustrate how uropathogenic E. coli use the multifunctional virulence factor TcpC to attenuate innate immune responses in the urinary tract.
- Published
- 2016
34. Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective
- Author
-
Nicholas J. Shields, Silke Neumann, Mary Chebib, Thomas Balle, and Andrew N. Clarkson
- Subjects
alpha7 Nicotinic Acetylcholine Receptor ,Ischemia ,Inflammation ,Review ,Brain damage ,Biology ,Catalysis ,immune response ,Inorganic Chemistry ,lcsh:Chemistry ,Immune system ,medicine ,Animals ,Humans ,Physical and Theoretical Chemistry ,Molecular Biology ,Stroke ,lcsh:QH301-705.5 ,Spectroscopy ,nicotinic acetylcholine receptor agonist ,Innate immune system ,Organic Chemistry ,General Medicine ,medicine.disease ,stroke ,Immunity, Innate ,Computer Science Applications ,Nicotinic agonist ,lcsh:Biology (General) ,lcsh:QD1-999 ,inflammation ,myeloid cells ,Immunology ,Cholinergic ,medicine.symptom ,Neuroscience ,nicotinic - Abstract
Stroke is one of the leading causes of death and long-term disability, with limited treatment options available. Inflammation contributes to damage tissue in the central nervous system across a broad range of neuropathologies, including Alzheimer's disease, pain, Schizophrenia, and stroke. While the immune system plays an important role in contributing to brain damage produced by ischemia, the damaged brain, in turn, can exert a powerful immune-suppressive effect that promotes infections and threatens the survival of stroke patients. Recently the cholinergic anti-inflammatory pathway, in particular its modulation using α7-nicotinic acetylcholine receptor (α7-nAChR) ligands, has shown potential as a strategy to dampen the inflammatory response and facilitate functional recovery in stroke patients. Here we discuss the current literature on stroke-induced inflammation and the effects of α7-nAChR modulators on innate immune cells.
- Published
- 2015
35. The flavonoid, 2'-methoxy-6-methylflavone, affords neuroprotection following focal cerebral ischaemia
- Author
-
Navnath Gavande, Silke Neumann, Kimmo Jensen, Liang Jin, Emma K. Gowing, Petra S. van Nieuwenhuijzen, Andrew N. Clarkson, Raghavendra Y. Nagaraja, Mai Marie Holm, Lily Boothman-Burrell, Jane R. Hanrahan, Philip K. Ahring, Zita Dósa, Mary Chebib, Kim Parker, and Joseph A. Nicolazzo
- Subjects
Male ,Flavonoid ,Inflammation ,Pharmacology ,Inhibitory postsynaptic potential ,Neuroprotection ,Tonic (physiology) ,Brain Ischemia ,03 medical and health sciences ,Mice ,0302 clinical medicine ,medicine ,Animals ,Receptor ,GABA Modulators ,chemistry.chemical_classification ,Mice, Knockout ,Mice, Inbred BALB C ,GABAA receptor ,business.industry ,Brain ,Synaptic Potentials ,Flavones ,Receptors, GABA-A ,Stroke ,Disease Models, Animal ,Neuroprotective Agents ,Neurology ,chemistry ,Cerebral ischaemia ,Original Article ,Neurology (clinical) ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,030217 neurology & neurosurgery - Abstract
Tonic inhibitory currents, mediated by extrasynaptic GABAA receptors, are elevated at a delay following stroke. Flavonoids minimise the extent of cellular damage following stroke, but little is known about their mode of action. We demonstrate that the flavonoid, 2′-methoxy-6-methylflavone (0.1–10 µM; 2′MeO6MF), increases GABAA receptor tonic currents presumably via δ-containing GABAA receptors. Treatment with 2′MeO6MF 1–6 h post focal ischaemia dose dependently decreases infarct volume and improves functional recovery. The effect of 2′MeO6MF was attenuated in δ−/− mice, indicating that the effects of the flavonoid were mediated via δ-containing GABAA receptors. Further, as flavonoids have been shown to have multiple modes of action, we investigated the anti-inflammatory effects of 2′MeO6MF. Using a macrophage cell line, we show that 2′MeO6MF can dampen an LPS-induced elevation in NFkB activity. Assessment of vehicle-treated stroke animals revealed a significant increase in circulating IL1β, TNFα and IFγ levels. Treatment with 2′MeO6MF dampened the stroke-induced increase in circulating cytokines, which was blocked in the presence of the pan-AKT inhibitor, GSK690693. These studies support the hypothesis that compounds that potentiate tonic inhibition via δ-containing GABAA receptors soon after stroke can afford neuroprotection.
- Published
- 2018
36. Effects of an exergame software for older adults on fitness, activities of daily living performance, and quality of life
- Author
-
Ursula Meidert, Silke Neumann, Heidrun Becker, Rakel Poveda-Puente, and Ricard Barberà-Guillem
- Subjects
Gerontology ,Male ,Quality of life ,Health (social science) ,Activities of daily living ,Statistics, Nonparametric ,Endurance ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Software ,Activities of Daily Living ,Fitness ,Humans ,030212 general & internal medicine ,Daily living performance ,Aged ,Aged, 80 and over ,business.industry ,Rehabilitation ,Public Health, Environmental and Occupational Health ,030229 sport sciences ,Original Articles ,Middle Aged ,Computer Science Applications ,Exercise Therapy ,610: Medizin und Gesundheit ,Video Games ,Physical Fitness ,Spain ,Older adults ,Female ,business ,Psychology ,Switzerland - Abstract
[EN] Background: As people become older, the biological process of aging leads to a decline in functional capabilities, which entails difficulties in the performance of daily tasks. Within the "Active and Assisted Living Joint Programme" a consortium from Spain, Germany, and Switzerland developed an interactive Exergame software for older adults to maintain their physical abilities and independence within the daily tasks. Subjects and Methods: An interventional study was conducted to validate the software. For 3 months, Swiss and Spanish seniors used the system at least three times a week for minimum half an hour in their homes. The physical condition in terms of maintaining or increasing strength, balance, safety, and mobility of the seniors was assessed by using the Berg Balance Scale and the Senior Fitness Test. In addition, the effect on independence within the activities of daily living was assessed by using the Canadian Occupational Performance Measure, the Performance Quality Rating Scale, and the Iconographical Falls Efficacy Scale. We used the EQ 5D to evaluate the "quality of life." Results: Twenty-nine participants (male; n= 14; female; n= 15) completed the study. Scores of endurance (2 minutes step test; P=0.01, eta(2) = 0.3) increased significantly. Moderate effect sizes in quality of life (r= 0.3), lower body strength (eta(2)= 0.08), and large effect sizes in endurance (eta(2) = 0.3) were detected. A small effect was evaluated within the gait speed (r= 0.2), mobility in the lower body (r= 0.2), and the balance capabilities (r= 0.2). Conclusion: The results of this study lead us to the conclusion that physical training with activity-focused exergames that are related to the everyday tasks of older adults could help to maintain and improve the individual fitness status., This project was funded by the AAL Joint Programme: Call AAL-2012-5, ICT-based solutions for supporting occupation in life of older adults and the Swiss Confederation, Federal Department of Economic Affairs, Education and Research. We thank all our partners of the consortium as well as all seniors who participated in the project.
- Published
- 2018
37. Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8 + T-cell responses and prevent tumour progression
- Author
-
Silke Neumann, Sarah Hook, Katie Young, Gavin F. Painter, Regan J. Anderson, and Benji Compton
- Subjects
Injections, Subcutaneous ,Galactosylceramides ,chemical and pharmacologic phenomena ,CD8-Positive T-Lymphocytes ,Biology ,Pharmacology ,Cancer Vaccines ,Epitope ,Interferon-gamma ,Immune system ,Antigen ,medicine ,Animals ,Immunologic Factors ,Cytotoxic T cell ,Cationic liposome ,Interferon gamma ,Melanoma ,Liposome ,General Veterinary ,General Immunology and Microbiology ,Public Health, Environmental and Occupational Health ,Survival Analysis ,Intramolecular Oxidoreductases ,Mice, Inbred C57BL ,Treatment Outcome ,Infectious Diseases ,Liposomes ,Immunology ,Molecular Medicine ,Administration, Intravenous ,CD8 ,T-Lymphocytes, Cytotoxic ,medicine.drug - Abstract
The lipid antigen α-galactosylceramide (α-GalCer) is a potent activator of invariant natural killer T-cells (iNKT cells) and can stimulate cytotoxic and anti-tumour immune responses. However optimal responses appear to be induced by α-GalCer when cell-based vaccines are delivered intravenously. Here we investigated if co-delivery of protein and peptide antigens along with α-GalCer in a liposomal formulation could stimulate therapeutic anti-tumour immune responses. Cationic liposomes were inherently immune-stimulatory and induced cytotoxic immune responses when delivered both by intravenous and subcutaneous injection. However, only vaccine delivered intravenously stimulated therapeutic anti-tumour immune responses to a peptide antigen. Surface modification with polyethylene glycol (PEG) did not improve immune responses to either intravenously or subcutaneously delivered vaccines. Immune responses to short and long peptide sequences (CD8 and CD4 epitopes) of the self-antigen tyrosinase-related protein 2 (TRP2) as a vaccine antigen, co-delivered with α-GalCer in either cationic liposomes or PBS were further examined. Enhanced production of IFN-γ, increased cytotoxic T-cell responses and tumour survival were observed when a long TRP2-peptide was delivered with α-GalCer in cationic liposomes.
- Published
- 2015
38. Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
- Author
-
Marie von Lilienfeld-Toal, Oliver A. Cornely, Lena M Biehl, Gero Massenkeil, Michael Sandherr, Silke Neumann, Marcus Hentrich, and Olaf Penack
- Subjects
Male ,Oncology ,medicine.medical_specialty ,viruses ,Antineoplastic Agents ,Breast Neoplasms ,Guideline ,Medical Oncology ,medicine.disease_cause ,Antiviral Agents ,Autologous stem-cell transplantation ,Germany ,Internal medicine ,medicine ,Humans ,Autografts ,Societies, Medical ,Hepatitis B virus ,Leukemia ,business.industry ,Antiviral prophylaxis ,Varicella zoster virus ,Hematology ,General Medicine ,Entecavir ,Hepatitis B ,medicine.disease ,Transplantation ,Virus Diseases ,Cancer treatment ,Acute Disease ,Practice Guidelines as Topic ,Alemtuzumab ,Original Article ,Female ,business ,Viral hepatitis ,Stem Cell Transplantation ,medicine.drug - Abstract
Reactivation of viral infections is common in patients with solid tumour or haematological malignancy. Incidence and severity depend on the extent of cellular immunosuppression. Antiviral prophylaxis may be effective to prevent viral reactivation. In 2006, the Infectious Diseases Working Party of German Society for Hematology and Medical Oncology (DGHO) published guidelines for antiviral prophylaxis in these patient populations. Here, we present an update of these guidelines for patients with solid and haematological malignancies undergoing antineoplastic treatment but not allogeneic stem cell transplantation. Relevant literature for reactivation of different viruses (herpes simplex virus (HSV), varicella zoster virus (VZV), hepatitis B virus (HBV) and respiratory viruses) is discussed to provide evidence-based recommendations for clinicians taking care of this patient population. We recommend a risk-adapted approach with (val)acyclovir against HSV and VZV in patients treated with alemtuzumab, bortezomib or purine analogues. Seasonal vaccination against influenza is recommended for all patients with solid or haematological malignancies regardless of antineoplastic therapy. Hepatitis B screening is recommended in lymphoproliferative disorders, acute leukaemia, and breast cancer, and during treatment with monoclonal anti-B-cell antibodies, anthracyclines, steroids and in autologous stem cell transplantation. In those with a history of hepatitis B prophylactic lamivudine, entecavir or nucleotide analogues as adefovir are recommended to prevent reactivation.
- Published
- 2015
39. Universal Response-Adaptation Relation in Bacterial Chemotaxis
- Author
-
Anna K. Krembel, Victor Sourjik, and Silke Neumann
- Subjects
Chemotaxis ,Stimulation ,Articles ,Biology ,Adaptation, Physiological ,Microbiology ,Universal relation ,Bacterial protein ,Bacterial Proteins ,Escherichia coli ,Receptor clustering ,Adaptation ,Biological system ,Receptor ,Molecular Biology ,Function (biology) - Abstract
The bacterial strategy of chemotaxis relies on temporal comparisons of chemical concentrations, where the probability of maintaining the current direction of swimming is modulated by changes in stimulation experienced during the recent past. A short-term memory required for such comparisons is provided by the adaptation system, which operates through the activity-dependent methylation of chemotaxis receptors. Previous theoretical studies have suggested that efficient navigation in gradients requires a well-defined adaptation rate, because the memory time scale needs to match the duration of straight runs made by bacteria. Here we demonstrate that the chemotaxis pathway of Escherichia coli does indeed exhibit a universal relation between the response magnitude and adaptation time which does not depend on the type of chemical ligand. Our results suggest that this alignment of adaptation rates for different ligands is achieved through cooperative interactions among chemoreceptors rather than through fine-tuning of methylation rates for individual receptors. This observation illustrates a yet-unrecognized function of receptor clustering in bacterial chemotaxis.
- Published
- 2015
40. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA study
- Author
-
Alexander S. Kekulé, Meinolf Karthaus, Peter Staib, Markus Ruhnke, Thomas Weber, Isabelle Bekeredjian-Ding, Axel Hamprecht, Philipp Koehler, Katrin Schulz, Corinna Hahn-Ast, Oliver Bader, Silke Neumann, Oliver A. Cornely, Stefan Schwartz, Peter M. Keller, Stefan W. Krause, Philippe Schafhausen, Gottfried Doelken, Michael G. Kiehl, Johannes Elias, Carolin Krämer, Paul La Rosée, Holger Rohde, Enrico Schalk, Maria J G T Vehreschild, Gerhard Haase, Maria Vergoulidou, Gerda Silling, Andrew J. Ullmann, Dieter Buchheidt, University of Zurich, and Vehreschild, Maria J G T
- Subjects
0301 basic medicine ,Azoles ,Male ,Posaconazole ,Antifungal Agents ,Aspergillosis ,2726 Microbiology (medical) ,Aspergillus fumigatus ,0302 clinical medicine ,Germany ,Epidemiology ,2736 Pharmacology (medical) ,Pharmacology (medical) ,030212 general & internal medicine ,Prospective Studies ,Case report form ,Aged, 80 and over ,Invasive Pulmonary Aspergillosis ,biology ,10179 Institute of Medical Microbiology ,Incidence (epidemiology) ,Incidence ,General Medicine ,Middle Aged ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,3. Good health ,Leukemia, Myeloid, Acute ,Infectious Diseases ,Aspergillus ,Female ,Cohort study ,medicine.drug ,Microbiology (medical) ,Adult ,medicine.medical_specialty ,Adolescent ,030106 microbiology ,610 Medicine & health ,03 medical and health sciences ,Young Adult ,Drug Resistance, Fungal ,Internal medicine ,medicine ,Animals ,Humans ,Aged ,Voriconazole ,business.industry ,2725 Infectious Diseases ,medicine.disease ,biology.organism_classification ,Surgery ,570 Life sciences ,business - Abstract
Invasive aspergillosis (IA) is a serious hazard to high-risk haematological patients. There are increasing reports of azole-resistant Aspergillus spp. This study assessed the epidemiology of IA and azole-resistant Aspergillus spp. in patients with acute leukaemia in Germany. A prospective multicentre cohort study was performed in German haematology/oncology centres. The incidence of probable and proven aspergillosis according to the revised EORTC/MSG criteria was assessed for all patients with acute leukaemia [acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL)]. Cases were documented into a web-based case report form, and centres provided data on standards regarding prophylactic and diagnostic measures. Clinical isolates were screened centrally for azole resistance and, if applicable, underlying resistance mechanisms were analysed. Between September 2011 and December 2013, 179 cases of IA [6 proven (3.4%) and 173 probable (96.6%)] were diagnosed in 3067 patients with acute leukaemia. The incidence of IA was 6.4% among 2440 AML patients and 3.8% among 627 ALL patients. Mortality at Day 84 was 33.8% (49/145) and attributable mortality was 26.9% (39/145). At Day 84, 53 patients (29.6%) showed a complete response, 25 (14.0%) a partial response and 17 (9.5%) a deterioration or failure. A total of 77 clinical Aspergillus fumigatus isolates were collected during the study period. Two episodes of azole-resistant IA (1.1%) were caused by a TR/L98H mutation in the cyp51A gene. With only two cases of IA due to azole-resistant A. fumigatus, a change of antifungal treatment practices in Germany does not appear warranted currently.
- Published
- 2017
41. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
- Author
-
Markus Ruhnke, Helmut Ostermann, Silke Neumann, Georg Maschmeyer, Michael Sandherr, Dieter Buchheidt, Christina Rieger, Daniela Tacke, Oliver A. Cornely, Andrew J. Ullmann, Meinolf Karthaus, K. E. Schweer, Olaf Penack, and Stefan W. Krause
- Subjects
Adult ,Azoles ,Oncology ,medicine.medical_specialty ,Posaconazole ,Antifungal Agents ,Allogeneic transplantation ,Opportunistic Infections ,Neutropenia ,Chemoprevention ,Immunocompromised Host ,Germany ,Internal medicine ,Amphotericin B ,medicine ,Humans ,Intensive care medicine ,Societies, Medical ,Voriconazole ,business.industry ,Micafungin ,Hematology ,General Medicine ,medicine.disease ,Primary Prevention ,Transplantation ,Mycoses ,Hematologic Neoplasms ,Practice Guidelines as Topic ,business ,Fluconazole ,medicine.drug - Abstract
Invasive fungal infections cause substantial morbidity and mortality in immunocompromised patients, particularly in those with haematological malignancies and recipients of allogeneic haematopoietic stem cell transplantation. Difficulties in diagnosing invasive fungal infections and subsequent delays in treatment initiation lead to unfavourable outcomes and emphasise the importance of prophylaxis. Since the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology in 2009, results of 14 additional clinical studies have been published comprising 2,899 patients and initiating this update. Key recommendations for adult patients are as follows: Posaconazole remains the drug of choice during remission-induction chemotherapy in acute myeloid leukaemia, myelodysplastic syndrome and allogeneic haematopoietic stem cell transplantation with graft versus host disease (AI). In the pre-engraftment period of allogeneic transplantation, several antifungals are appropriate and can be recommended with equal strength: voriconazole (BI), micafungin (BI), fluconazole (BI) and posaconazole (BII). There is poor evidence regarding antifungal prophylaxis in the post-engraftment period of allogeneic haematopoietic stem cell transplantation if no steroids for treatment of graft versus host disease are required. Aerosolised liposomal amphotericin B inhalation in conjunction with fluconazole can be used in patients with prolonged neutropenia (BII).
- Published
- 2014
42. Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants
- Author
-
Silke Neumann, Thomas Rades, Roslyn A. Kemp, Sarah Hook, Kristina Burkert, and P. Rod Dunbar
- Subjects
Male ,Inflammasomes ,medicine.medical_treatment ,Freund's Adjuvant ,Interleukin-1beta ,Immunology ,Peripheral blood mononuclear cell ,Cathepsin B ,Microbiology ,Mice ,Immune system ,Adjuvants, Immunologic ,Antigen ,NLR Family, Pyrin Domain-Containing 3 Protein ,medicine ,Animals ,Humans ,Immunology and Allergy ,Secretion ,Chitosan ,Chemistry ,Interleukin ,Inflammasome ,Cell Biology ,In vitro ,Cell biology ,Alum Compounds ,Nanoparticles ,Female ,Carrier Proteins ,Adjuvant ,medicine.drug - Abstract
Particulate vaccine formulations, designed to improve the delivery of antigens to antigen-presenting cells (APCs) and to stimulate an immune response, have been shown to activate the NLRP3 inflammasome. This leads to the processing and secretion of interleukin (IL)-1β, which supports the recruitment of pro-inflammatory immune cells into the tissue and can therefore be beneficial for vaccine potency. Recent work suggested that this may be a common mechanism of action for all particulate formulations. The aim of this study was to investigate whether the activation of the NLRP3 inflammasome was common to many delivery systems. We prepared polymer-based chitosan nanoparticles (CNPs), lipid-based cubosomes, a water in oil emulsion of incomplete Freund's adjuvant (IFA) and alum formulations and examined inflammasome activation in vitro using murine bone-marrow-derived dendritic cells and human peripheral blood mononuclear cells and in vivo in mice. The formulations differed in their morphology, size and zeta-potential. Only the positively charged particles (CNPs and alum) were able to activate the inflammasome and increase the secretion of IL-1β. A decrease in the activation of the inflammasome with these particulates was observed when cathepsin B-mediated effects were blocked, implying a role of lysosomal rupture in the activation process. These findings demonstrate a role for the surface charge of particulates in the activation of the NLRP3 inflammasome, which should be considered when designing a novel vaccine formulation.
- Published
- 2014
43. Pharmacokinetics of Meropenem in Critically Ill Patients With Severe Infections
- Author
-
Sebastian Hoppe, Harald Schwörer, Lutz Binder, Silke Neumann, Rolf Wachter, Michael Oellerich, Philip D. Walson, Frank Streit, and Annett Beckmann
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.drug_class ,Critical Illness ,Antibiotics ,MEDLINE ,Microbial Sensitivity Tests ,Infections ,030226 pharmacology & pharmacy ,Meropenem ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Pharmacokinetics ,law ,Internal medicine ,polycyclic compounds ,medicine ,Humans ,Pharmacology (medical) ,Prospective Studies ,Intensive care medicine ,Prospective cohort study ,Aged ,Retrospective Studies ,Aged, 80 and over ,Pharmacology ,0303 health sciences ,Hematology ,030306 microbiology ,business.industry ,Retrospective cohort study ,Middle Aged ,biochemical phenomena, metabolism, and nutrition ,bacterial infections and mycoses ,Intensive care unit ,Anti-Bacterial Agents ,3. Good health ,Intensive Care Units ,Female ,Thienamycins ,business ,medicine.drug - Abstract
Meropenem is an effective β-lactam antibiotic that is frequently used to treat serious infections in both intensive care unit (ICU) and febrile neutropenic hematology/oncology (Hem/Onc) patients. Studies suggest that to be effective, meropenem concentrations must be maintained above the inhibitory concentrations for the majority of a dosing interval. However, the pharmacokinetics (PK) of meropenem seem to differ in critically ill patients compared with healthy or less ill subjects used to select labeled dosing regimens.This study was designed to investigate meropenem PK in critically ill patients and to see how often standard dosing regimens produced adequate plasma concentrations. A secondary objective was to investigate how achieved concentrations were related to outcomes (morbidity and mortality) in these patients.Meropenem plasma concentrations over time were measured using a high pressure liquid chromatography assay in febrile Hem/Onc and ICU patients who were treated with standard meropenem dosing schedules. Outcomes such as fever control and survival were assessed in these patients and compared with individual meropenem PK data and with recommended target concentrations.A total of 25 subjects including 10 febrile Hem/Onc and 15 ICU patients with a variety of serious illnesses and baseline renal function were studied. Mean peak concentrations were less variable than were pre-dose concentrations. Post peak and trough concentrations were often below recommended minimum inhibitory concentrations. Both clearance and volumes of distribution were greater than reported in less ill subjects, only in part explained by increased renal clearance. Therefore, serum concentrations often did not exceed recommended concentration targets even for moderately sensitive organisms. Inadequate concentrations were especially common in the mostly ill, febrile neutropenic Hem/Onc subjects and seemed to explain at least some therapeutic failures. Conversely, drug accumulation occurred in ICU subjects with decreased renal function.Standard meropenem dosing regimens were inadequate in many critically ill febrile, neutropenic Hem/Onc, and septic ICU patients. These data suggest a role for meropenem concentration monitoring in such patients.
- Published
- 2013
44. Physical Ergonomics at Translators’ Workplaces: Findings from Ergonomic Workplace Assessments and Interviews
- Author
-
Maureen Ehrensberger-Dow, Ursula Meidert, Silke Neumann, and Heidrun Becker
- Subjects
poste de travail ,traduction professionnelle ,medicine.medical_specialty ,Engineering ,Medical education ,Shoulders ,business.industry ,problèmes de santé ,professional translation ,Professional development ,Human factors and ergonomics ,Computer users ,ergonomie ,health complaints ,évaluation de l’ergonomie ,workplace ,Physical Ergonomics ,ergonomics ,Physical therapy ,medicine ,business ,ergonomic assessment - Abstract
Most professional translators in the Western world are heavy computer users and thus may be exposed to health risks known to be associated with computer work. These include musculoskeletal ailments of the upper extremities, back, shoulders, arms, hands and problems with the eyes. This paper reports on the findings of workplace assessments and interviews with professional translators with respect to the ergonomics of their workplaces and related health issues. A total of 36 professional translators working as freelancers, in institutional settings or in commercial enterprises were visited at their workplaces. Each workplace was assessed and compared to the recommendations about ergonomics available in the literature. In addition, interviews were held with translators immediately after the assessments about their current health status and any recent complaints. Many of the assessed workplaces evinced a high standard of ergonomically appropriate equipment and furniture. However, the equipment was in many cases not adjusted to suit the ergonomic needs of the individual using the workplace. Although the level of complaints was low overall, the highest number of health complaints related to the eyes, neck and shoulder girdle. Frequent breaks, changing position and doing short exercises to loosen up tense muscles would address these problems by helping to reduce tension and pain in the neck, shoulders and back and by providing rest for the eyes. Whenever possible, an ergonomic consultation is recommended. It is also recommended that ergonomic knowledge about proper workplace set-up should be provided in professional training. La plupart des traducteurs professionnels occidentaux restent assis de longues heures devant leur écran et s’exposent ainsi aux problèmes de santé liés au travail à l’ordinateur. Parmi ces problèmes, il convient de citer les troubles musculo-squelettiques du dos, des épaules, des bras et des mains et la fatigue oculaire. Le présent article expose les résultats des évaluations et interviews réalisées auprès de traducteurs professionnels et axées sur l’ergonomie de leur poste de travail et les problèmes de santé associés. Les chercheurs se sont rendus aux postes de travail de 36 traducteurs professionnels installés à leur compte ou engagés dans des institutions ou des entreprises commerciales. Chaque poste de travail a fait l’objet d’une évaluation et d’une comparaison avec les recommandations en matière d’ergonomie fournies par la littérature. Des interviews ont, en outre, été menées avec les traducteurs à l’issue des évaluations dans le but de connaître leur état de santé et d’éventuels problèmes récents. Une grande partie des postes évalués présentent un équipement et un mobilier dotés d’un niveau élevé d’ergonomie. Toutefois, l’agencement n’est pas toujours adapté aux besoins ergonomiques de la personne assignée au poste de travail. Même si, dans l’ensemble, le nombre de problèmes de santé exprimés reste faible, la majorité d’entre eux concernent les yeux, la nuque et la ceinture scapulaire. Pauses fréquentes, changements de position et brefs exercices de relaxation permettraient de soulager ces problèmes en apaisant les tensions et les douleurs au niveau du dos, des épaules et de la nuque et en reposant les yeux. Il est recommandé de procéder à une analyse ergonomique dans la mesure du possible et de sensibiliser l’auditoire à l’agencement adéquat du poste de travail dans le cadre de formations professionnelles.
- Published
- 2016
45. An International Survey of the Ergonomics of Professional Translation
- Author
-
Heidrun Becker, Gary Massey, Andrea Hunziker Heeb, Maureen Ehrensberger-Dow, Ursula Meidert, and Silke Neumann
- Subjects
Occupational therapy ,Engineering ,medicine.medical_specialty ,Knowledge management ,ergonomie physique ,German ,ergonomie cognitive ,ergonomie organisationnelle ,Translation studies ,medicine ,organizational ergonomics ,cognitive ergonomics ,Cognitive ergonomics ,traduction professionnelle ,Medical education ,business.industry ,professional translation ,Human factors and ergonomics ,technologie langagière ,General Medicine ,language.human_language ,Language technology ,physical ergonomics ,language ,Professional association ,language technology ,Portuguese ,business - Abstract
Despite the fact that professional translation is characterized by human-machine interaction, the ergonomics of the professional translation workplace is relatively under-researched. In order to gain further insights into how translators worldwide have set up and organized their workplaces, an anonymous online survey was developed by a team of researchers in translation studies and occupational therapy as part of an interdisciplinary project. It was made available in six languages (English, French, German, Italian, Portuguese, and Spanish) and distributed through multipliers such as professional organizations. The interest that this topic generated in the professional community was reflected not only in the large number of completed questionnaires (1,850) but also by the comments provided by translators both in the survey itself and in email messages to the research team. This paper reports on the findings of the survey with a focus on differences existing among commercial, institutional, and freelance translators in different countries and the degree to which language technology is involved in professional translation. Findings are compared to good practice recommendations for computer work, and conclusions are drawn with respect to health issues related to suboptimal ergonomics. Alors même que la traduction professionnelle se caractérise par une interaction entre l’humain et la machine, l’ergonomie chez les traductrices et traducteurs professionnels reste un domaine relativement peu exploré. Dans le but de recueillir des informations sur la façon dont les traductrices et traducteurs à travers le monde ont agencé et organisé leur poste de travail, des chercheuses en traductologie et en ergothérapie ont réalisé une étude en ligne anonyme dans le cadre d’un projet interdisciplinaire. Traduit en six langues (français, anglais, allemand, italien, portugais et espagnol), le questionnaire relatif à cette étude fut envoyé par des multiplicateurs, par exemple des organisations professionnelles. L’intérêt suscité par la question au sein de la communauté professionnelle se reflète dans le grand nombre de questionnaires complétés (1 850), mais aussi dans les commentaires formulés par les traducteurs dans l’étude elle-même et dans les courriels adressés à l’équipe de chercheuses. Le présent article expose les résultats de l’étude et met l’accent sur les disparités entre traducteurs commerciaux, institutionnels et indépendants dans les différents pays et sur le degré de pénétration de la technologie langagière dans la traduction professionnelle. Les résultats font l’objet d’une comparaison avec les recommandations en matière de bonnes pratiques dans le travail à l’ordinateur et servent de base à l’analyse des problèmes de santé liés à une ergonomie insuffisante.
- Published
- 2016
46. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
- Author
-
Georg Maschmeyer, Olaf Penack, Dgho, Sabine Mousset, Werner J. Heinz, Michael G. Kiehl, Jörg Janne Vehreschild, Gerda Silling, Hermann Einsele, Silke Neumann, Marrow Transplantation, Andrew J. Ullmann, Stefan Neuburger, Hartmut Bertz, William Krüger, and Martin Schmidt-Hieber
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Graft vs Host Disease ,Hematopoietic stem cell transplantation ,Infections ,Medical Oncology ,Communicable Diseases ,03 medical and health sciences ,0302 clinical medicine ,Anti-Infective Agents ,Internal medicine ,Germany ,medicine ,Parasitic Diseases ,Humans ,Transplantation, Homologous ,Viral ,030212 general & internal medicine ,ddc:610 ,Intensive care medicine ,Societies, Medical ,Hematology ,Bacteria ,business.industry ,Vaccination ,Hematopoietic Stem Cell Transplantation ,General Medicine ,Guideline ,Bacterial Infections ,Transplantation ,Haematopoiesis ,Fungal ,Mycoses ,Virus Diseases ,030220 oncology & carcinogenesis ,Practice Guidelines as Topic ,Original Article ,Stem cell ,business - Abstract
Annals of hematology 95(9), 1435-1455 (2016). doi:10.1007/s00277-016-2711-1, Published by Springer, Berlin
- Published
- 2016
47. Einsatz der Slackline in der Neurorehabilitation
- Author
-
Roger Stadelmann and Silke Neumann
- Abstract
Die Slackline ist ein Trainingsgerat, mit dem uberwiegend Kletterer und Boulderer ihre Gleichgewichtsfahigkeit schulen. Ihren Ursprung hat die Slackline 1980 in den USA, als Kletterbegeisterte im Yosemite Nationalpark anstatt auf einer starren Absperrkette eines Parkplatzes auf einem Nylonband, das sie zwischen zwei Baumen spannten, balancierten. Mittlerweile trainieren damit nicht nur Kletterer, sondern auch im Sportunterricht und als Freizeitbeschaftigung gewinnt die Slackline immer mehr an Bedeutung. Silke Neumann und Roger Stadelmann zeigen, wie sie die Slackline als Therapiegerat in der neurologischen Rehabilitation einsetzen, und komplettieren ihren Artikel durch drei Erfahrungsberichte von Patienten, die eine Slackline-Therapie erfolgreich hinter sich gebracht haben.
- Published
- 2012
48. Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients
- Author
-
Marie von Lilienfeld-Toal, Peter Staib, Jörg J. Vehreschild, Oliver A. Cornely, Maria J G T Vehreschild, Mohammed Wattad, Arne M K Meissner, Meinholf Karthaus, Hildegard Christ, Silke Neumann, Martin Hellmich, and Georg Maschmeyer
- Subjects
Adult ,Male ,medicine.medical_specialty ,Abdominal pain ,Neutropenia ,Time Factors ,Adolescent ,medicine.medical_treatment ,Antineoplastic Agents ,Risk Factors ,Neoplasms ,Intensive care ,Internal medicine ,medicine ,Humans ,Aged ,Aged, 80 and over ,Chemotherapy ,business.industry ,Incidence ,Incidence (epidemiology) ,Cancer ,Syndrome ,Original Articles ,Hematology ,Middle Aged ,Inflammatory Bowel Diseases ,medicine.disease ,Surgery ,Clinical trial ,Defecation ,Female ,Mitoxantrone ,medicine.symptom ,business - Abstract
Background Neutropenic patients are at risk of abdominal complications and yet the incidence and impact of these complications on patients’ morbidity and mortality have not been sufficiently evaluated. We aimed to assess a clinical rule for early detection of abdominal complications leading to death or transfer to intensive care in patients with chemotherapy-associated neutropenia. Design and Methods This observational multicenter study was carried out in seven German hematology-oncology departments. For inclusion, neutropenia of at least 5 consecutive days was required. Risk factors for “transfer to intensive care” and “death” were assessed by backward-stepwise binary logistic regression analyses. Chemotherapy-associated bowel syndrome was defined as a combination of fever (T ≥37.8 °C) and abdominal pain and/or lack of bowel movement for 72 hours or more. Five hundred and twenty-one neutropenic episodes were documented in 359 patients. Results The incidence of chemotherapy-associated bowel syndrome was 126/359 (35%) in first episodes of neutropenia. Transfer to intensive care occurred in 41/359 (11%) and death occurred in 17/359 (5%) first episodes. Chemotherapy-associated bowel syndrome and duration of neutropenia were identified as risk factors for transfer to intensive care ( P
- Published
- 2011
49. Example of the application of the PERSONA methodology in the definition of needs and requirements for the WeTakeCare system
- Author
-
Ricard, Barbera-Guillem, Rakel, Poveda-Puente, Silke, Neumann, Heidrun, Becker, Miguel, Ramírez, Arno, Wienholtz, and Inge, Schaedler
- Subjects
Aged, 80 and over ,Male ,Activities of Daily Living ,Humans ,Female ,Middle Aged ,Self-Help Devices ,Geriatric Assessment ,Needs Assessment ,Aged - Abstract
In user-centred design and marketing, personas are fictional characters created to represent the different user types that might use a site, brand, or product in a similar way [1]. As in other projects, the main application and use value of the persona approach in WeTakeCare project has been to depict and thus make "vivid" the characters and the milieus created and selected. It has helped to better understand and communicate the differences among the potential users. It has also helped to understand the heterogeneity and diversity of the users' lives and to focus on how to meet their actual needs [2].
- Published
- 2015
50. Langzeit Ergebnisse der randomisierten Phase 2 Studie zur Verbesserung der adjuvanten Chemotherapie beim frühen NSCLC – Vergleich Cisplatin/Pemetrexed (CPx) mit Cisplatin/Vinorelbine (CVb) (TREAT)
- Author
-
Michael Thomas, Silke Neumann, M Thomer, Walburga Engel-Riedel, Juergen R. Fischer, W. Eberhardt, Georgios Stamatis, Thomas Graeter, Martin Reck, Jens Kollmeier, N. Frickhofen, P De Leyn, C Schuhmann, Michael Kreuter, Johan Vansteenkiste, Monika Serke, Frank Griesinger, and Heike Zabeck
- Subjects
Pulmonary and Respiratory Medicine - Published
- 2015
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.